To view the Open Payments physician payment dataset, click here: www.cms.gov/openpayments
SUNSHINE ACT DISCLOSURES OFF TO CLOUDY START (Orthopedics This Week)
Ready or not and 33% incomplete, CMS (Centers for Medicare and Medicaid Services) released the first round of Open Payments data on September 30, 2014.
The big news?
Big Pharma Rules
We did a quick review of the 4.4 million payments for a total of $3.5 billion paid to 546,000 individual physicians and almost 1,360 teaching hospitals for the last five months of 2013 and found most of it came from Big Pharma and heart device makers.
Companies like Eli Lilly & Company, Shire U.S. Holdings, Forest Laboratories, Amgen, St. Jude Medical, Astra Zeneca Pharmaceutical, Cordis, Ethicon and Johnson & Johnson (non-ortho) dominated the listings.
Seeking Alpha reported that Roche’s Genentech unit led the way in the non-research category with $135 million. Most of this (90%) went to a Southern California hospital network for royalties. Bristol-Myers Squibb was #1 in the research category with $329 million which, according to the company, was largely the value of experimental medicines used in studies. Medtronic, Inc. paid one uniden...
